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Human telomeres are protected from DNA damage
by a nucleoprotein complex that includes the
repeat-binding factor TRF2. Here, we report that
TRF2 regulates the 50 exonuclease activity of its
binding partner, Apollo, a member of the metallo-b-
lactamase family that is required for telomere integ-
rity during S phase. TRF2 and Apollo also suppress
damage to engineered interstitial telomere repeat
tracts that were inserted far away from chromosome
ends. Genetic data indicate that DNA topoisomerase
2a acts in the same pathway of telomere protection
as TRF2 and Apollo. Moreover, TRF2, which binds
preferentially to positively supercoiled DNA sub-
strates, together with Apollo, negatively regulates
the amount of TOP1, TOP2a, and TOP2b at telo-
meres. Our data are consistent with a model in which
TRF2 and Apollo relieve topological stress during
telomere replication. Our work also suggests that230 Cell 142, 230–242, July 23, 2010 ª2010 Elsevier Inc.cellular senescence may be caused by topological
problems that occur during the replication of the
inner portion of telomeres.
INTRODUCTION
Telomeres are essential for the maintenance of chromosome
stability (Blackburn, 2001). The key to how telomeres perform
this function resides in very special features that prevent their
recognition as, and the accidental generation of, DNA double-
strand breaks (Lundblad, 2000). Among the many mammalian
telomere-associated proteins identified in the past decade, telo-
mere repeats binding factor 2 (TRF2) plays a crucial role in pro-
tecting chromosome ends against instability (Bilaud et al., 1997;
Broccoli et al., 1997; van Steensel et al., 1998). TRF2 binds
specifically to double-stranded telomeric DNA and is copurified
from nuclear extracts with five other telomeric proteins (TRF1,
TIN2, TPP1, POT1, and Rap1), which form a multiprotein
complex called shelterin (Palm and de Lange, 2008). Notably,
TRF2 appears to associate with telomeres in distinct complexes,
whose exact composition and biological significance remain to
be determined (Mattern et al., 2004). Upon TRF2 inhibition, telo-
meres associate with DNA damage response factors, forming
telomere dysfunction-induced foci (TIFs) (Takai et al., 2003).
The different aspects of telomere damage response are very
similar to those elicited by the double-strand breaks induced
by ionizing radiation (Denchi and de Lange, 2007).
The visualization of purified telomeric DNA from various eu-
karyotic organisms has revealed that at least some chromo-
somal termini adopt a looped configuration called t loop (Griffith
et al., 1999). T loops have been proposed to protect chromo-
some ends from degradation and repair. Therefore, the contribu-
tion of TRF2 to telomere end protection may be explained, at
least in part, by its role in t loop formation. Indeed, in vitro studies
have shown that TRF2 can remodel a telomeric DNA substrate
into a t loop (Stansel et al., 2001), a reaction probably facilitated
by an unwinding activity (Amiard et al., 2007).
In addition to its DNA binding role, TRF2 recruits a number of
factors and enzymes required for telomere protection, including
Apollo, (Freibaum and Counter, 2006; Lenain et al., 2006; van
Overbeek and de Lange, 2006), an Artemis paralog, which, inter-
estingly, is also involved in DNA repair (Bae et al., 2008; Demuth
et al., 2008; Demuth et al., 2004). Reduced expression of Apollo
causes telomere defects in S phase cells and accelerates the
onset of senescence in primary fibroblasts (van Overbeek and
de Lange, 2006). The mechanism by which Apollo controls telo-
mere replication and senescence is not known. The fact that
Apollo exhibits a 50 exonuclease activity in vitro (Lenain et al.,
2006) suggests that an Apollo-mediated nucleolytic step could
be required to protect telomeres. In this study, we present
evidence that the nuclease domain of Apollo is required to
protect the internal tracts of telomeric repeats from DNA damage
and is regulated by TRF2. Moreover, we found that topoisomer-
ase 2a (TOP2a) acts in synergy with TRF2 and Apollo for telo-
mere protection. We propose a model in which TRF2 regulates
the Apollo-mediated processing of topologically constrained
structures that occur during telomere replication.RESULTS
TRF2 Regulates the Exonuclease Activity of Apollo
We first asked whether the 50 exonuclease activity of Apollo can
be modulated by TRF2. When Apollo was incubated with purified
TRF2, its 50 exonuclease activity on a single-stranded telomeric
substrate was stimulated (Figures 1A and 1B). TRF2 did not stim-
ulate the 50 exonuclease activity of RecJf or Artemis (Figures 1A–
1C) and enhanced Apollo 50 exonuclease activity on a blunt
substrate that ended with a nontelomeric sequence (Figure 1D),
while purified TRF2 alone did not modify the substrate (Figures
S1A and S1B available online). TRF1 did not stimulate the
nuclease activity of Apollo (Figures 1B and 1C).
TRF2 inhibited Apollo activity on substrates that mimics telo-
meric DNA ends, i.e., 50 recessed strands of double-stranded
substrates ending with 30 G tails (Figure 1E). This could stem
from the preferential binding of TRF2 to the junction between
the single- and the double-stranded part of the telomeric DNA
(Stansel et al., 2001), physically preventing the access of Apollo
to its substrate.The stimulating effect of TRF2 on exonuclease activity did
not lead to an observable activation of an endonuclease
activity. The same result was obtained in the presence of puri-
fied DNA-PK under conditions in which this kinase phosphory-
lates and activates Artemis (Figure 1 and data not shown).
Therefore, the existence of any endonuclease activity for Apollo
remains hypothetical.
TheNucleaseDomain of Apollo Is Required for Telomere
Protection and Prevention of Senescence
The regulation of Apollo exonuclease activity by TRF2 leads
credence to the view that this catalytic activity is involved in telo-
mere protection. To test this hypothesis, we constructed three
alleles of Apollo bearing mutations in conserved residues within
the metallo-b-lactamase domains (Apm1, 2, and 3) of Apollo,
Artemis, and hSNM1 (Figure S1C) (Pannicke et al., 2004; Poin-
signon et al., 2004). We substituted one histidine (H33) or aspar-
tate (D14, D35) residue either separately in Apm2 (D35N) and
Apm3 (D14N) or as a double substitution in Apm1 (H33A,
D35N). In contrast to wild-type Apollo, the purified mutants did
not display any cleavage activity when tested with a single-
stranded substrate in vitro (Figure S1B). These results are in
agreement with a previous mutation comparable to D35N that
abolished the exonuclease activity of hSNM1 (Hejna et al.,
2007). It is interesting that mutations of D14, H33, and D35 in
Artemis impaired its endonucleolytic activity but left its exonu-
cleolytic activity intact (Pannicke et al., 2004), although recent
results seem to question the reality of this latter exonucleolytic
activity (Pawelczak and Turchi, 2010). These discrepancies
among the in vitro properties of Apollo, Artemis, and hSNM1—
together with the fact that unlike hSNM1 (Hejna et al., 2007),
Apollo does not seem to use RNA substrates (data not
shown)—suggest that these three paralogs display distinct cata-
lytic properties, likely to translate into different functions.
The wild-type and nuclease-inactive alleles of Apollo were ex-
pressed in human cells as green fluorescent protein (GFP)
C-terminal fusions using retroviral vectors. These GFP-tagged
proteins were named Apwt-G, Apm1-G, Apm2-G, and Apm3-G,
respectively. The presence of a tag at the C terminus of Apollo
did not modify the nuclease activity of Apollo in vitro (data not
shown) (Lenain et al., 2006). In addition, these Apollo constructs
were mutated to remove the target site for the small interfering
RNA (siRNA) against Apollo (CL2 siRNA, Figure S1D), previously
selected for its ability to diminish Apollo expression and cause
telomere deprotection (Lenain et al., 2006). Both Apwt-G and
mutant proteins were expressed in vivo at similar levels and
were present at telomeres (Figures S2A–S2C). The fact that the
nuclease activity is not required for targeting Apollo to telomeres
confirms previous data showing that the TRF2-interacting region
of Apollo lies outside of its nuclease domain (Chen et al., 2008;
Lenain et al., 2006)
The expression of Apwt-G in Apollo-proficient cells did not
lead to the loss of telomere protection and did not alter cell-cycle
progression (Figures S2D and S2E). This, together with the fact
that cells exhibiting the highest and lowest levels of Apwt-G
display a similar number of foci containing both the checkpoint
protein 53BP1 and the telomere marker protein TRF1, two
features of TIFs (Figure S2F) (Takai et al., 2003), indicates thatCell 142, 230–242, July 23, 2010 ª2010 Elsevier Inc. 231
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Figure 1. TRF2 Stimulates Apollo 50-30
Exonuclease Activity
(A) Denaturing PAGE analysis of DNA products ob-
tained after digestion of ssTelT (left), AH41 (right)
by Apollo and Artemis in the presence of TRF2.
Increasing amounts of TRF2 (molar ratio TRF2/
nuclease: 0.1, 0.5, 1, 5, 15) were added to 4 ng
TEV1-digested Apollo or 20 ng Artemis prior to
incubation with DNA.
(B) Quantification of Apollo, RecJf, and Artemis
activities as a function of the molar ratio between
TRF1 or TRF2 and the various nucleases.
Cleavage stimulation was calculated as the ratio
of the fraction of DNA cleaved in the presence
and in the absence of TRF proteins. The data are
represented as mean ± SD.
(C) Same experiment as in (A), with Apollo and
TRF1 or RecJf and TRF2.
(D) Denaturing PAGE analysis of DNA products ob-
tained after digestion of dsTelT labeled on the top
strandby 4 ng TEV1-digested Apollo in the absence
or presence of a 5-fold molar excess of TRF2.
(E) Left: denaturing PAGE analysis of DNA products
obtained after digestion of dsTelT labeled on the
bottom strand by 4 ng TEV1-digested Apollo in
the presence of increasing amounts of TRF2 (molar
ratio TRF2/Apollo: 0.1, 0.5, 1, 5, 15). Right: quanti-
fication of Apollo activity as a function of the molar
ratio between TRF2 and Apollo. Cleavage stimula-
tion was calculated as in (C). The data are repre-
sented as mean ± SD.
See also Figure S1.the level of Apollo expression in our retroviral expression system
did not alter telomere function.
Next, we asked whether the ectopic expression of wild-type or
mutant GFP-tagged Apollo rescues the loss of telomere protec-
tion that occurs when the endogenous Apollo gene is repressed.
Transfection of CL2 siRNA led to an increased number of TIFs in
the absence, but not in the presence, of Apwt-G (Figures 2A and
2B), supporting the idea that Apwt-G complements Apollo defi-
ciency. To test whether complementation can occur at a lower
level of ectopic expression, we expressed a short hairpin RNA
(shRNA) that targeted both the endogenous and exogenous
alleles of Apollo (named shAp) together with GFP or Apwt-G.
The expression of shAp led to a marked reduction in the quantity
of Apollo messenger RNA (mRNA) and an increased number of
TIFs in GFP control cells but not in Apwt-G cells. As expected,
the level of Apwt-G was reduced markedly in knockdown (KD)
cells but remained above the physiological level of endogenous
Apollo mRNA (about 6-fold) (Figure S2G). We also investigated232 Cell 142, 230–242, July 23, 2010 ª2010 Elsevier Inc.whether Apwt-G complements other
Apollo knockdown phenotypes. We
have previously shown that knockdown
ofApollo exacerbates the telomere fusion
phenotype induced by the expression of
the dominant negative allele of TRF2
(Lenain et al., 2006). Therefore, we ex-
pressed Apwt-G in TRF2-compromised
and Apollo-depleted cells and monitoredthe rate of telomere fusions (Lenain et al., 2006). As expected,
the expression of Apwt-G rescued the increased rate of fusions
induced by the transfection of CL2 siRNA in TRF2DBDM cells
(Figures S2I). We concluded that retrovirally expressed Apwt-G
is able to rescue the major telomere dysfunction phenotypes
linked to a reduced amount of endogenous Apollo protein.
We found that the nuclease-inactive alleles did not rescue the
telomere deprotection phenotype (Figures 2A and 2B). More-
over, the expression of the nuclease-inactive allele Apm1-G in
TRF2DBDM cells depleted of endogenous Apollo enhanced the
rate of telomere fusions, generating long chains of joined chro-
mosomes (Figures S2I and S2J) similar to those observed in
TRF2 knockout cells (Celli and de Lange, 2005). In contrast to
Apwt-G, the overexpression of mutants in wild-type cells exerted
a dominant-negative effect, leading to a greater number of TIFs
(Figure S2D). The dominant-negative effect of the mutants can
be explained simply by their incorporation at telomeres (Figures
S2A–S2C) and the subsequent displacement of the endogenous
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Figure 2. Induction of DNA Damage Signals and Telomere Aberrations in Apollo Compromised Cells
(A) Representative images of confocal sections of 53BP1 foci (red) and TRF1 (green) in nuclei of HT1080 cells expressing either wild-type (Apwt-G) or mutant
(Apm1-G) forms of Apollo or GFP and transfected with CL2 siRNA. White arrows indicate colocalization between 53BP1 and TRF1. The magnification of the
images is shown as a scale bar (5 mm).
(B) Quantification of TIFs shown in (A) as well as in nuclei of cells retrovirally transduced for a shRNA directed against the coding region of Apollo. The data are
represented as mean ± SD. The p value corresponds to the comparison of Apwt-G and three Apollo mutants.
(C) Representative images of the main telomeric aberration encountered in Apollo-compromised cells (STD, single-telomere deletion; DTD, double-telomere
deletion; TD, telomere doublets; STA, sister telomere association).
(D, E, and G) Quantification of telomeric aberrations in metaphase spreads of cells expressing Apwt-G and three Apollo mutants as percentage of events per
chromosome. The telomere deletions were determined by eye inspection of the metaphases. The numbers in brackets on the x axis indicate the numbers of
chromosomes counted in each cell type. The data are represented as mean ± SD.
(F) Enlarged images of chromosomes with STD or DTD. The circles indicate the remaining faint signals.
(G) The data are represented as mean ± SD. The p value corresponds to the comparison between Apwt-G and three Apollo mutants.
(H) Representative images of telomere Q-FISH showing chromosomes with STD affecting both leading and lagging telomeres.
(I) Quantitative analysis of STD on lagging and leading sister chromatids after replication. The data are represented as mean ± SD.
* indicates a p value of < 0.05. See also Figures S2, S3, and S4.Apollo protein. As expected, the expression of nuclease-inactive
mutants, but not of wild-type Apollo, accelerated the onset of
senescence in telomerase-negative cells (Figures 3A and 3B),
demonstrating that the nuclease domain is required for Apollo-
mediated prevention of cellular senescence.
The Nuclease Domain of Apollo Controls Telomere
Integrity during Replication
As previously observed in Apollo KD cells (van Overbeek and de
Lange, 2006), the expression of the nuclease-inactive alleles of
Apollo increases the number of telomeric signals at chromosome
termini (telomere doublets or TDs; Figures 2C and 2D). The origin
of such telomere aberrations remains unknown, but might berelated to accidents during telomere replication, as those
observed in TERF1 knockout mouse cells (Sfeir et al., 2009).
However, in contrast to the usual form of replicative damage
(Branzei and Foiani, 2009), Apollo-dysfunctional cells do not
activate the ATR pathway of DNA damage response and do
not exhibit extensive regions of single-stranded DNA (Figure S3)
(van Overbeek and de Lange, 2006).
Again, similar to Apollo KD cells (Lenain et al., 2006; van Over-
beek and de Lange, 2006), the expression of the nuclease-
inactive alleles of Apollo in TRF2-proficient cells did not trigger
interchromosome telomeric fusions but augmented the
frequency of sister telomere associations (STAs; Figures 2C
and 2E). These STAs presumably perturbed mitotic segregation,Cell 142, 230–242, July 23, 2010 ª2010 Elsevier Inc. 233
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Figure 3. Accelerated Onset of Senescence
and Increase in Nucleoplasmic Bridges in
Cells Expressing Nuclease-Inactive Alleles
of Apollo
(A) Cell proliferation arrests in response to the
expression of nuclease-inactive Apm1 mutant in
primary fibroblasts.
(B) Representative microscopic images of
b-galactosidase staining in primary cells.
(C) Representative images of one normal binu-
cleate cell with counterstaining of b-tubulin (red),
which shows the cytoskeleton between the binu-
cleated cells and DAPI stain (blue).
(D) Typical image of one narrow nucleoplasmic
bridge.
(E) The relatively wide nucleoplasmic bridges in
one binucleate cell in HT1080 cells expressing
Apm1-G.
(F) The percentage of nucleoplasmic bridges was
scored in at least 1000 binuclei in each indicated
cell condition. The data are represented as
mean ± SD.leading to higher numbers of nucleoplasmic bridges in cytoki-
nesis-blocked binucleated cells (Figures 3C–3F) (Fenech, 2007).
We also observed a significant increase in the rate of telomere
deletion upon Apollo dysfunction, both by telomeric DNA stain-
ing on metaphase spreads (Figures 2C, 2F, and 2G) and by
terminal restriction fragment analysis (Figures S4A and S4B). In
almost 80% of the deletions, faint telomeric PNA signals could
still be detected at chromosome ends (Figure 2F). This suggests
that most of the time, the damage occurred within the telomere
repeat tracts and not in sub- or terminal telomeric regions. In
accordance with previous data showing that telomere abnormal-
ities in Apollo-compromised cells can affect telomeres regard-
less of their replication mode (van Overbeek and de Lange,
2006), we found that the single telomere deletions affected
both leading and lagging telomeres (Figures 2H and 2I). More-
over, the nuclease-inactive mutant cells did not differentially alter
the length of sister telomeres (Figures S4C and S4D).
To further analyze the role of Apollo during replication, we
used a combination of BrdU incorporation and ChIP assay to234 Cell 142, 230–242, July 23, 2010 ª2010 Elsevier Inc.measure the amount of replicating DNA
associated with telomeric proteins (Ver-
dun and Karlseder, 2006). HT1080 cells
expressing either Apwt-G or Apm1-G
were synchronized by treatment with
a sublethal dose of hydroxyurea (HU)
that blocks cell cycle progression at the
G1/S boundary. Cells were then released
in fresh medium and, prior to harvesting
at individual time points, were incubated
with BrdU for 1 hr. Cell-cycle progression
was analyzed by FACS, and the DNA
content was used as a reference for
determining the cell-cycle phase. The
expression of Apm1-G did not modifycell-cycle progression at the indicated time points (Figure 4A),
and the cells incorporated BrdU to the same extent as those ex-
pressing Apwt-G (Figure 4B), including at the telomeres (Fig-
ure 4C). Of note, there is a higher BrdU incorporation at telo-
meres at the 2 hr time point in the former case. This might be
explained by an early replication of bulk telomeric DNA or telo-
meric repair after HU release or both. Remarkably, Apm1-G cells
had more TRF1 bound to telomeres during replication compared
to GFP or Apwt-G cells (Figures 4D and 4E, data not shown) and
less BrdU in chromatin fragments bound to anti-TRF1 antibodies
(Figures 4F and 4G). The concomitant TRF1 enrichment and
delay in replication of TRF1-enriched telomeres in cells express-
ing Apm1-G raises the possibility that TRF1, and perhaps other
shelterin components, is enriched in telomeric regions encoun-
tering replication problems. Alternatively, the nuclease domain
of Apollo might be required for an efficient replication of TRF1-
enriched telomeric regions or of telomeric DNA damaged by
HU or both. Collectively, the presence of doublets and the
massive telomere deletion, as well as the replication delay in
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Figure 4. Apollo Dysfunction Triggers a Replication Delay in TRF1-Enriched Telomeric Chromatin
(A) FACS analysis of cells released from G1/S block at the time points indicated.
(B) Total BrdU incorporation in the genome. The data are represented as mean ± SD.
(C) The amount of telomeric DNA in the total DNA immunoprecipitated with anti-BrdU antibodies was assayed by slot blot. The data are represented as
mean ± SD.
(D) ChIP experiments on synchronized cells incubated with BrdU. Precipitations were performed with antibodies against TRF1. The precipitated DNA was
analyzed by slot blot with telomeric and Alu probes.
(E) Densitometric evaluation of the experiment shown in (D) and two other independent experiments. The data are represented as mean ± SD.
(F) Detection of BrdU on the slot blot of TRF1 ChIP by hybridization and exposure to anti-BrdU antibodies.
(G) Densitometric evaluation of the experiment shown in (F) and three other independent experiments. The data are represented as mean ± SD.TRF1-enriched telomeric chromatin, indicates that mutations
that abolish the nuclease activity of Apollo affect proper telomere
replication.
The Nuclease Domain of Apollo Protects Interstitial
Telomere Repeat Tracts from DNA Damage
Next, we examined the possibility that Apollo could be involved
in the progression of the replication fork through telomeric chro-
matin. To this end, we adapted in human cells an experimental
setting used previously in S. pombe to distinguish terminal
from internal events during telomere replication (Miller et al.,2006). This approach, based on the study of telomeric DNA inte-
grated interstitially in chromosomes, has been used to demon-
strate that Taz1p, a TRF1/TRF2 ortholog, is required for efficient
fork progression through the telomeric chromatin (Miller et al.,
2006).
We took advantage of the SNG28 human cell line, containing
an 800 bp long interstitial telomeric sequence that has been ar-
tificially integrated in approximately the middle of chromosome 4
long arm (called the 4qITS) (Figure 5A) (Desmaze et al., 2004).
TRF2 and Apollo specifically bound to this interstitial repeat in
Apwt-G and Apm1-G cells (Figure 5A and Figure S5). The resultsCell 142, 230–242, July 23, 2010 ª2010 Elsevier Inc. 235
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Figure 5. The Nuclease Domain of Apollo Protects Interstitial Telomeric DNA from Breakage
(A) Schematic representation of the 800 bp long interstitial telomeric sequence (4qITS) artificially integrated in the middle of chromosome 4q in SNG28 cells.
Comparative staining of metaphase chromosomes with a specific 4qITS green probe and a red-labeled chromosome 4 painting probe. ChIPs were revealed
by qPCR of fragments located 0.2 kb and 1.5 kb from the 4qITS and of sequences in the ANT1 and FRG1 genes located approximately 4.8 and 0.4 Mb from
the starting position of telomeric DNA at the end of chromosome 4q.
(B) Representative images of confocal sections using FISH staining of the 4qITS region (green) and IF staining of 53BP1 (red). The magnification of the images is
shown as a scale bar (20 mm for HT1080 cells expressing empty and TRF2DBDM nuclei; 5 mm for Apwt-G, Apm1-G, shCtl and shPOT1 nuclei).
(C) The percentage of colocalizing signals using the 4qITS probe and 53BP1 antibodies in (B). The data are represented as mean ± SD.
(D) Representative images of confocal sections using FISH staining of the 4qITS and 4qITS regions and IF staining of 53BP1 in HT1080 cells treated with 3 mg/ml
ICRF-193, 1 mM RHPS4, and 1 mM hydroxyurea for 24 hr. 4qST indicates a probe specific of the 4q subtelomeric region. The magnification of the images is shown
as a scale bar (5 mm). The data are represented as mean ± SD.
(E) The percentage of colocalizing signals using the 4qITS probe and 53BP1 antibodies in (D).
* indicates a p value of < 0.05. See also Figures S5 and S6.were in accordance with the previously observed binding of
TRF2 to interstitial repeats in hamster (Smogorzewska et al.,
2000) and human (Mignon-Ravix et al., 2002) cells.
As in HT1080 cells, the expression of Apm1-G, but not of
Apwt-G, in SNG28 cells led to a potent DNA damage response
at telomeres (Figure S6A). Moreover, the expression of Apm1 or
TRF2DBDM specifically triggered a potent DNA damage response
at the 4qITS, as revealed by ChIP with antibodies against
the phosphorylated form of H2AX (gH2AX; Figure 5A) and by
the colocalization of 4qITS with 53BP1 (Figures 5B and 5C). Its
occurrence cannot be explained by the spreading of the chro-
matin modification from a damaged 4q telomere because the
ITS is inserted at a distance beyond the observed limit of this
spreading (d’Adda di Fagagna et al., 2003) (Figure 5A).
Then, we asked whether POT1 is involved in the replication of
4qITS telomeres. First, we failed to detect any POT1 binding to
4qITS (Figure 5A) while the same ChIP experiment revealed
POT1 binding to terminal telomeric repeats (Figure S6B).
Although POT1 has been shown to bind (presumably indirectly)
to the double-strand portion of telomeres, the length of the telo-236 Cell 142, 230–242, July 23, 2010 ª2010 Elsevier Inc.meric sequence at 4qITS may be too short to allow enough POT1
recruitment detectable in our experimental conditions (Takai
et al., 2010). Second, a POT1 reduced expression (Figures 5A–
5C), or the treatment with the G4 ligand RHPS4, which leads to
the displacement of POT1 (Salvati et al., 2007) (Figures 5D and
5E), does not elicit DNA damage at the interstitial telomeric
DNA, although it does at the telomeres of the same cells (Figures
S6C and S6D). Therefore, POT1 does not appear to be required
for the replication of 4qITS. The fact that POT1 and RHPS4
trigger a potent DNA damage response at telomeres but not at
4qITS argues against the hypothesis of a trans-spreading reac-
tion being responsible for the recruitment of gH2AX and 53BP1
at the 4qITS region.
Apollo and TRF2 help TOP2a in Protecting Telomeric
DNA
Intriguingly, we found that a reduced expression of topoisomer-
ase 2a (encoded by TOP2A; Figure 6A) induced a marked
increase in telomere damage that was not further incremented
in the context of Apm1-G mutant cells (Figures 6B; see
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Figure 6. Apollo and TRF2 Assist TOP2a to Protect Telomeres
(A) Images of confocal sections show reduced expression of TOP1 or TOP2a (red) in HT1080 cells processed 3 days after their transfection with siRNA targeting
TOP1, TOP2 a and mock gene.
(B) Bar graph showing the mean number of TIFs per nucleus. The p values indicate the comparison between Apm1-G and the GFP nuclei. The data are repre-
sented as mean ± SD.
(C) Overexpression of Apwt-G or TRF2 rescues the telomere dysfunction induced by the treatmentwith ICRF-193 or siRNATOP2a, as examined by IF. The bar graph
shows the mean number of TIFs per nucleus. The p values indicate the comparison between Apwt-G and the GFP nuclei. The data are represented as mean ± SD.
(D) Telomeric ChIPs were performed using HT1080 cells infected with the indicated viral vector. Duplicate slot blots were probed for telomeric or Alu DNA.
(E) Quantification of the data in (D). The relative association of various topoisomerases with telomeric or Alu DNA was calculated by normalizing the percentage
of telomeric DNA recovered in each ChIP to that recovered in cells transfected with the control vectors. The data are represented as mean ± SD.
(F) Representatives images of nuclei with high (left) and low (right) level of TOP2a in HT1080 cells overexpressing wild-type Apollo (Apwt-G) or control cells over-
expressing GFP. The rectangle indicates an area of the nucleus, which is shown enlarged at the top of the panel. White arrows indicate foci with a colocalization
of TOP2a and telomeric PNA. Images were generated by projection of optical sections acquired at 0.3 mM intervals with the LSM-500 confocal imaging system
from Zeiss. The entire nucleus is presented. The scale bar represents 5 mm.
(G) Representative image of a field of cells costained with PCNA and TOP2a antibodies as well as with PNA Telo probe. The magnification of the image is shown
as a scale bar (20 mm).
(H) Bar graph showing the average number of colocalized TOP2a and telomeric PNA foci in various subsets of cells. The data are represented as mean ± SD.
* indicates a p value of < 0.05. See also Figure S7.
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Figure S7A for representative images of TIF analyses). In agree-
ment with a telomere protective role of TOP2 enzymes, treat-
ment with ICRF-193, a catalytic inhibitor of TOP2a and TOP2b,
induced a robust recruitment of 53BP1 at telomeres (Figure 6C)
as well as at the 4q ITS (Figures 5D and 5E). Remarkably, the
telomere deficiencies due to TOP2a knockdown or ICRF-193
treatment were rescued by increasing the expression of TRF2
or Apollo (Figure 6C). In contrast, knockdown of the expression
of topoisomerase 1 (TOP1; Figure 6A) did not lead to an increase
TIF formation and did not prevent Apm1-G allele damage to the
telomere (Figure 6B). Overall, these data support the view that
TRF2 and Apollo work on complementary pathways with
TOP2a, and perhaps TOP2b, in maintaining telomere integrity.
The increased number of TIFs in response to ICRF-193 treat-
ment was not correlated with a global increase in DNA damage
(Figure S7B). Conversely, addition of a sublethal dose of the
radiomimetic drug bleomycin triggered a global enhancement
of DNA damage (Figure S7C) but did not increase significantly
the number of TIFs (Figure S7D). Therefore, the telomeres
appear to be more sensitive than the rest of the genome to the
lack of topoisomerase 2 activity.
TRF2 and Apollo Control the Amount of Topoisomerase
at Telomeres
Given that a role of TOP2a is to solve topological problems
arising around the replication fork (Nitiss, 2009), two modes of
action for TRF2 and Apollo can be envisioned: either they
decrease the level of superhelical stress or they increase the
recruitment or activation of TOP2. Consistent with this, we
observed that the overexpression of TRF2 or Apollo decreased
the amount of TOP1, TOP2a, and TOP2b bound at telomeres
as measured by ChIP (Figures 6D and 6E) and by confocal
microscopy analysis (Figure 6F, data not shown).
If the interplay between TRF2, Apollo, and TOP2 is involved in
telomere replication, the decrease in TOP2 after Apollo or TRF2
overexpression should occur during S phase. To test this
hypothesis, we costained telomeric DNA and TOP2a with
PCNA (proliferating cell nuclear antigen), which preferentially
reveals S phase cells. As expected, TOP2a accumulates in the
nucleus of PCNA-positive cells (Figure 6G) (Heck et al., 1988).
The PCNA-negative cells that exhibit a high level of TOP2a are
likely to be in G2 or G2/M and those with no or faint level of
TOP2a in G1 (Heck et al., 1988). The number of colocalized telo-
meres and TOP2a foci was determined only in the fraction of
cells exhibiting a detectable level of TOP2a. In control cells,
the telomere/TOP2a colocalized foci are enriched in PCNA-posi-
tive cells but not in PCNA-negative cells, showing that this asso-
ciation is cell cycle specific (Figures 6G and 6H). In the case of
Apollo overexpression, as well as of TRF2, the number of colo-
calized foci in S phase drops significantly (Figures 6G and 6H).
These data indicate that a high dosage of TRF2 or Apollo
reduces the requirement of TOP2a for telomere replication.
TRF2 Exhibits Preferential Binding to Positively
Supercoiled DNA
The aforementioned results raised the intriguing possibility that
TRF2 acts as a sensor of a topological problem during replica-
tion. Since the denaturation of the parental duplex causes posi-238 Cell 142, 230–242, July 23, 2010 ª2010 Elsevier Inc.tive superhelical strain in the replicating molecule (Postow et al.,
2001), it is interesting that TRF2, but not TRF1, induces positive
supercoiling by wrapping DNA around itself in a right-handed
manner (Amiard et al., 2007). This suggests that its binding to
positive supercoils could be energetically favored, a hypothesis
that could be tested in vitro.We found that a positively supercoiled
plasmid DNA containing a stretch of telomeric sequence was
a much better competitor for TRF2 binding on a linear substrate
than the same plasmid DNA in either its negatively supercoiled
or relaxed forms (Figure 7A). In contrast, TRF1 binding was in-
hibited equally by all three forms (Figure 7B). In agreement with
the fact that the wrapping property of TRF2 does not depend on
the sequence-specific C-terminal Myb domain (A.P., E.G., and
M.J.G.P., unpublished data), TRF2 also binds preferentially to
positively supercoiled non telomeric plasmid DNA than relaxed
or negatively supercoiled DNA (Figures S1E–S1G).
The preferred binding to positive supercoiled DNA could mani-
fest itself in vivo through an increased binding of TRF2 to telo-
meric DNA under positive topological stress. Indeed, in ChIP
experiments, we observed an increased amount of TRF2 at telo-
meres in cells treated with ICRF-193 (Figure 7C). Notably, we
also observed a slight increase in the binding of TRF1, which
might reflect an enhanced recruitment to telomeres of the entire
shelterin complex in the context of topological stress.
DISCUSSION
This study demonstrates that TRF2 and Apollo dysfunction
trigger a potent DNA damage response at an interstitial telomere
repeat tract where this sequence is not part of a functional telo-
mere structure (Figure 5). This observation clearly supports a role
of these proteins in the protection of the inner portion of telo-
meric tracts during replication and attests to the paramount
importance of telomeric capping proteins in the tight control of
telomere replication (Sfeir et al., 2009; Miller et al., 2006). More-
over, this works reveals a functional link between TRF2, the 50
exonuclease activity of Apollo and DNA topology during telo-
mere replication, raising the question of how the positive super-
helical strain generated during replication is resolved at chromo-
some ends.
TRF2 and Apollo Cooperate with Top2a to Maintain
Telomere Integrity during S Phase
Our study unveils that TRF2 and its partner exonuclease, Apollo,
act together with topoisomerase 2 to protect the inner portion of
telomeres from replicative damage and that TRF2-Apollo and
various topoisomerases are in balanced amounts at telomeres.
In agreement with a role of TOP2a during telomere replication,
the reduced association of topoisomerases with telomeres
upon overexpression of TRF2 or Apollo occurs specifically in S
phase cells (Figure 6H). In contrast, the treatment of cells by
ICRF-193, a topoisomerase catalytic inhibitor, leads to an
enhanced recruitment of TRF2 at telomeres. These results
suggest that TOP2a and TRF2-Apollo act in complementary
pathways involved in telomere replication.
The implication of TOP2a in telomere replication suggests that
TRF2 and Apollo deficiencies lead to the accumulation of pre-
catenates, structures that result from the entanglement of the
BA
     Telo  Probe            Alu Probe 
 DMSO    ICRF      DMSO    ICRF 
IgG
C
D
(+)
(++)
(+)
(+)
TRF2-
Apollo
Top2 
(++)
Topological 
 block 
 ollopA-2FRT ollopA-2FRT
TRF1
TRF2
pTelo2 
 Lin* 
wells
1 2 3 4 5 6 10 11 12 7 8 9 13 14 15 16 17 18 19 20 
- + + + + + + + + + + + + + TRF2
- - - - - - - - - - 
- - - - - - - - - - 
- - - - - - - - - - 
+SC
-SC
R
 + + + + + +
-
-
-
- - - 
- - - 
- - - 
pTelo2 
 Lin* 
-+ + + + + + + + + + + + + TRF1
- - - - - - - - - - 
- -- - - - - - - - 
- -- - - - - - - - 
+SC
-SC
R
1 2 3 4 5 6 10 11 12 7 8 9 13 14 
wells
pTelo2  
Lin*
wells
TRF2
1 2 3 4 5 6 10 11 7 8 9 
Figure 7. A Topology-Based Model for TRF2-Mediated Coupling of the Exonuclease Activity of Apollo to Telomere Replication
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(C) ChIP experiments were performed on cells treated with 3 mg/ml of ICRF-193 for 24 hr. The slot blot membrane was hybridized with telomeric DNA probe and
then with the Alu probe. IgG antibody was used as a negative control.
(D) Model for the cooperation between TRF2–Apollo and topoisomerases 2 to solve the topological stress that arises during telomere replication.
See also Figure S1.two replicated strands behind the replication fork and that can be
resolved by TOP2 (Damelin and Bestor, 2007). This possibility is
consistent with an increase in the rate of sister telomere associ-
ations (Figure 2) and nucleoplasmic bridges (Figure 3) in Apollo-
compromised cells. However, cells with both TOP2a and Apollo
deficiency do not show a detectable delay in G2/M (Figure S2E,
data not shown), suggesting either that the number of unre-
solved precatenates is too little to impact cell-cycle progression
or that these defects are rapidly transformed into DNA breaks.
Although the topological barriers unresolved in the absence of
Apollo might lead to stalled forks, no uncoupling of the replica-
tion fork is detected (Figure S3), suggesting that such replicative
damages are different from those often observed upon replica-
tion stress (Branzei and Foiani, 2009), in the absence of the
WRN helicase in human cells (Arnoult et al., 2009) or in TERF1
knockout mouse cells (Sfeir et al., 2009), and are more similar
to those provoked by an interstrand crosslink (Tourrie`re and
Pasero, 2007).It is interesting to note that TOP2 enzymes are present in
large amounts at the base of chromatin loops in metaphase
chromosomes (Gasser et al., 1986). This suggests that in addi-
tion to assisting the catalytic activity of TOP2a, TRF2 and Apollo
might contribute to the higher order organization of t loops.TheNuclease Activity of Apollo Is Required for Telomere
Replication and Topology Control
Given our observation that unbound TRF2 stimulates exonu-
clease activity, whereas the DNA-binding of TRF2 inhibits it
(Figure 1), it is possible that the nuclease activity of Apollo is
coupled to telomere replication through a transient release of
TRF2 upon fork passage. In vivo, three different nuclease-inac-
tive mutants of Apollo were unable to complement the telomere
defects caused by a reduced expression of Apollo, whereas the
wild-type form of Apollo was able to complement them (Figure 2).
Therefore, nuclease-inactive alleles are defective in a functionCell 142, 230–242, July 23, 2010 ª2010 Elsevier Inc. 239
required at telomeres to maintain their integrity during DNA
replication.
However, our results do not exclude other roles of the
nuclease domain of Apollo. For instance, in TRF2-compromised
cells, the nuclease-inactive mutants dramatically increase telo-
mere fusions of both the chromosome and chromatid types
(Figures S2H–S2J) (Lenain et al., 2006). This could reflect a
TRF2-independent function of Apollo in the prevention of telo-
mere fusion (Lam et al., 2010).
How do TRF2 and Apollo reduce the need for topoisomerases
at telomeres? One possibility is that Apollo and TRF2 process or
prevent the formation of topological barriers that would impede
the dissipation of superhelical strain during telomere replication.
These barriers may result from the various nucleoprotein struc-
tures that form at telomere (Gilson and Ge´li, 2007). For instance,
the nucleoprotein complex that stabilizes the basis of the t loop
might prevent the free rotation of the telomeric DNA. Similarly,
topological constraints can arise at interstitial telomeric DNA
through the formation of large chromosome loops created by
the invasion of the terminal telomeric single strand in duplex
DNA, as was proposed for the appearance of double-minute
chromosomes upon TRF2 and ERCC1/XPF dysfunction in
mouse (Zhu et al., 2003) and plant cells (Vannier et al., 2009).
Another nonexclusive possibility is that TRF2 and Apollo could
prevent fork reversal, as proposed previously for Exo1 (Cotta-
Ramusino et al., 2005). This is expected to maintain functional
forks at telomeres, thus leaving more time for the topoiso-
merases to solve topological problems. This function would
appear to be intriguingly similar to the role of the DNA damage
checkpoint in the stabilization of replication forks (Desany
et al., 1998; Lopes et al., 2001). This is also reminiscent of a situ-
ation in fission yeast in which a top2 mutant that blocks the
closed clamp DNA-enzyme complex rescues the telomere
defect of cells disrupted for the TRF1/TRF2 ortholog Taz1p
(Germe et al., 2009).
A TRF2-Sensing Model for the Control of Telomere
Topology
Interestingly, we found that TRF2, but not TRF1, preferentially
binds to positively supercoiled DNA and is enriched at telomeres
upon the loss of topoisomerase 2 activity. Hence, TRF2 might be
highly enriched near the fork, serving as a topological stress
sensor. The fact that the preferred binding of TRF2 to positive
supercoiled DNA is not restricted to telomeric DNA suggests
that TRF2 could even play this role throughout the genome.
Remarkably, in the Lyme disease bacterium Borrelia, positive
supercoiling stimulates the activity of the telomere resolvase
ResT by promoting its binding to DNA (Bankhead et al., 2006).
Therefore, use of the free energy of positive supercoiling gener-
ated by the replication of topologically constrained domains
appears to be a general mechanism, conserved from bacteria
to mammals, exploited by telomere proteins to facilitate telo-
mere replication. We propose that TRF2 binding to positively
supercoiled DNA orchestrates protein functions, including the
nuclease activity of Apollo, during fork passage to prevent aber-
rant telomere topology (Figure 7D).
In conclusion, telomere integrity during replication depends on
the concerted activities of TRF2-Apollo and TOP2 to release the240 Cell 142, 230–242, July 23, 2010 ª2010 Elsevier Inc.positive superhelical strain created by fork progression. Ensuring
correct telomere replication is expected to play a critical role in
development, longevity, and tumor suppression.EXPERIMENTAL PROCEDURES
DNA, RNA, and Protein Purification and Biochemistry Assays
The sequence design of three nuclease-inactive and resistant to siRNA CL2
Apollo mutants are shown in Figure S1. The protocol of nuclease activity
assays, telomere length analysis and chromatin immunoprecipitation was per-
formed as in Lenain et al. (2006).Cell Biology and Cytogenetic Analyses
Cell culture, transfections, virus production and infections, immunofluores-
cence, FISH, metaphase spread preparation, and microscopy techniques
were performed as in Lenain et al. (2006).Analyses of TRF1 Binding and BrdU Incorporation during S Phase
For synchronization, cells were incubated overnight with 0.5 mM hydroxyurea.
After release, cells were harvested every 2 hr. Chromatin immunoprecipitation
(ChIP) assay was performed as described previously (Salvati et al., 2007). For
BrdU incorporation into ChIP fragments, cells were incubated with 10 mM
BrdU (Sigma) for 1 hr at each time point.Statistical Analysis
According to the results of the univariate test, continuous normal variables
were expressed as means ± standard deviation (SD). Categorical variables
were expressed as percentages; comparisons between these groups were
analyzed with the chi-square test; the SD values for these groups were
analyzed on the basis of at least three independent experiments. Parametric
variables of normal distribution were analyzed by either a two-tailed t test or
the F test for analysis of variance followed by Duncan’s test for each two-group
comparison. Results were considered significant at p < 0.05. Statistical
analysis was performed using SAS 8.2 statistical package (SAS Institut,
Cary, NC).SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at doi:10.1016/j.cell.
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